My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies.

    Vettor R, Serra R, Fabris R, Pagano C, Federspil G.

    Diabetes Care. 2005 Apr;28(4):942-9.PMID: 15793204 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

    Clin Ther. 2004 Sep;26(9):1427-35.PMID: 15531005 [PubMed - indexed for MEDLINE]Related articles

    4.

    A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.

    McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group.

    Diabetes Care. 2003 Jan;26(1):125-31.PMID: 12502668 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

    Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

    Diabetes Obes Metab. 2000 Jun;2(3):175-87.PMID: 11220553 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

    McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD.

    Arch Intern Med. 2000 Jul 24;160(14):2185-91.PMID: 10904462 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.

    Gokcel A, Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N.

    Diabetes Care. 2001 Nov;24(11):1957-60.PMID: 11679464 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.

    Serrano-Rios M, Melchionda N, Moreno-Carretero E; Spanish Investigators.

    Diabet Med. 2002 Feb;19(2):119-24.PMID: 11874427 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.

    Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.

    Diabet Med. 2005 Aug;22(8):1024-30.PMID: 16026368 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.

    Kim SH, Lee YM, Jee SH, Nam CM.

    Obes Res. 2003 Sep;11(9):1116-23.PMID: 12972682 [PubMed - indexed for MEDLINE]Related articles

    11.

    Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.

    Kaukua JK, Pekkarinen TA, Rissanen AM.

    Int J Obes Relat Metab Disord. 2004 Apr;28(4):600-5.PMID: 14770192 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.

    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.

    Metabolism. 2008 Nov;57(11):1552-7.PMID: 18940393 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.

    Wang TF, Pei D, Li JC, Tsai WC, Tsai CC, Yao CY, Chang ET, Hsieh MC, Su KY, Kuo SW.

    Int J Clin Pract. 2005 Jul;59(7):746-50.PMID: 15963197 [PubMed - indexed for MEDLINE]Related articles

    14.

    The efficacy and safety of sibutramine for weight loss: a systematic review.

    Arterburn DE, Crane PK, Veenstra DL.

    Arch Intern Med. 2004 May 10;164(9):994-1003. Review.PMID: 15136309 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.

    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.

    Clin Ther. 2006 May;28(5):770-82.PMID: 16861099 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

    Diabetes Nutr Metab. 2004 Aug;17(4):222-9.PMID: 15575343 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term weight loss with sibutramine: a randomized controlled trial.

    Wirth A, Krause J.

    JAMA. 2001 Sep 19;286(11):1331-9.PMID: 11560538 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.

    Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K, Study Group SA; SAT Study.

    Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):201-7.PMID: 15127325 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J.

    Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004096. Review.PMID: 15674929 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects.

    Tankova T, Dakovska G, Lazarova M, Dakovska L, Kirilov G, Koev D.

    Acta Diabetol. 2004 Dec;41(4):146-53.PMID: 15660196 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity